AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Palbopro 125mg Capsule

Prescription Icon
Prescription Required

Marketer

RPG Life Sciences Ltd

Salt Composition

Palbociclib (125mg)

Overview Palbopro 125mg Capsule

For individuals with metastatic estrogen receptor-positive, HER2-negative breast cancer, Palbopro 125mg capsules are administered in conjunction with hormonal cancer treatments. Dosage is determined by your physician, with treatment length varying based on individual response. Regular blood monitoring is typical. Report any signs of infection (fever, chills, fatigue) immediately. Reliable contraception is crucial during treatment. Dizziness is a potential side effect; avoid driving or activities demanding concentration until its impact is known. Most side effects resolve upon discontinuation. A known side effect is neutropenia, a decrease in white blood cells weakening the immune system and increasing infection risk, though this usually resolves quickly after stopping the medication.

Uses of Palbopro 125mg Capsule

Malignant breast tumor

Major Benefits of Palbopro 125mg Capsule:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication.

Common Side effects of Palbopro 125mg Capsule:

  • Fatigue
  • Hair loss
  • Rash
  • Vomiting
  • Diarrhea
  • Nausea
  • Decreased appetite
  • Infection
  • Decreased white blood cell count
  • Stomatitis (Inflammation of the mouth)
  • Anemia (low number of red blood cells)
  • Weakness
  • Fever

How to use Palbopro 125mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication.

How Palbopro 125mg Capsule works:

Palbociclib 125mg capsules are an anti-neoplastic agent. Their mechanism involves blocking cyclin-dependent kinases 4 and 6, crucial proteins driving cellular replication. This inhibition halts the cancer cell cycle, effectively slowing tumor growth. Furthermore, this medication specifically targets estrogen receptor-positive breast cancers by interfering with cellular division.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Palbopro 125mg Capsules lacks established safety data. Physician consultation is advised.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Palbopro 125mg capsules during pregnancy poses a confirmed risk to the fetus. Prescribing it is uncommon except in life-threatening circumstances where potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not take Palbopro 125mg capsules. Evidence indicates potential infant harm from this medication.

DrivingDrivingNone

No drug interactions identified.

KidneyKidneyNone

No known drug interactions.

LiverLiverNone

No drug interaction detected.

What if you forget to take Palbopro 125mg Capsule :

NA

Facts to Know About Palbopro 125mg Capsule

LabelValue
Chemical Type Piperazine-pyridines
Developing Habits No.
Treatment Category Cancer Medications
Action Class CDK inhibitor

FAQs on Palbopro 125mg Capsule

Palbopro 125mg Capsules are an anti-cancer medication. They work by inhibiting cyclin-dependent kinase proteins, thereby slowing cancer cell growth and progression.
Treatment length varies individually. Your doctor determines the necessary treatment cycles based on your condition, response, and side effect tolerance. Treatment adjustments, including dose reduction or temporary/permanent discontinuation, may occur if side effects arise.
Palbopro 125mg Capsule side effects are largely reversible and resolve upon discontinuation. A known side effect is neutropenia, a decrease in white blood cells weakening the immune system and increasing infection risk. This effect, however, subsides quickly after stopping the medication.
Regular blood tests are crucial while taking Palbopro 125mg Capsule, as this medication can reduce blood cell counts (white blood cells, red blood cells, and platelets). These tests monitor the medication's effects and are scheduled for the start of each chemotherapy cycle, day 15 of the first two cycles, and as clinically necessary.
Palbopro 125mg capsules are typically taken once daily for 21 days, followed by a 7-day break, completing a 28-day cycle. Take with food at the same time each day. Swallow capsules whole; do not open, chew, or crush. Discard any damaged capsules. If you vomit after taking a dose, do not repeat it; resume your regular schedule.
Women of childbearing age taking Palbopro 125mg capsules, and their partners, must use effective contraception (such as a condom and diaphragm) throughout treatment and for at least three weeks afterward. Men using Palbopro 125mg capsules should use contraception for at least 14 weeks post-treatment.
Palbopro 125mg Capsule may impair male fertility; therefore, men should consider sperm banking before starting treatment.
Palbociclib 125mg capsules can cause serious side effects such as shortness of breath, dizziness, weakness, unusual bleeding (including nosebleeds or bruising), fever, chills, signs of infection, and rapid, irregular, or forceful heartbeat. Seek immediate medical attention if any of these occur.
Palbopro 125mg Capsule
32,176
MRP 39,200
17% off